Products - Rhone Ma Holdings Berhad

Home
Products
Page 4

Kruuse Monofast

Monofilament, synthetic absorbable polyglycolide-poly (e-caprolactone) copolymer (PGCL).

Violet colour.

Available in 4-0. Needle: round bodied, taper point 1/2 circle, 24mm.

Suture length: 70cm.

For soft tissue surgery, ligation, subcutaneous or intracutaneous suturing, GI surgery, urological surgery and suturing of oral cavity mucosa.

Kruuse Nylon
Features:
• Monofilament
• Synthetic
• Non-absorbable: provides permanent tensile strength
• Blue colour
• Polyamide 6&66 by extruding a strong uniform strand

Tensile Strength:
Range:
USP 3-0 to 2-0

Indications:
Indicated for soft tissue approximation and ligation, where permanent support is needed, including:
• Skin closure
• Ophthalmic surgery
• Vascular and cardiovascular surgery
• Neurosurgery

Needle: reverse cutting 3/8 circle, 70cm suture
Kruuse PD-X
Features:
• Monofilament
• Synthetic
• Absorbable: by hydrolysis
• Violet colour
• Polydioxanone (PDO)

Tensile Strength:
• 75% remains after 14 days
• 60% remains after 28 days
• Complete mass absorption in approximately 180-210 days

Range:
USP 3-0 to 2-0

Indications:
Indicated for soft tissue approximation and ligation, where absorbable sutures are indicated, including:
• Abdominal wall closure
• GI-surgery
• Fascia and ligaments
• Tendon repairs
• Hernias
• Orthopaedics
• Vascular surgery

Needle: round bodied, taperpoint ½ circle, 70cm suture
Kruuse Sacryl
Features:
• Multifilament
• Braided
• Synthetic
• Coated
• Absorbable: by hydrolysis
• Violet colour
• Polyglactin 910 (co-polymer of 90% Glycolide and 10% L-lactide)

Tensile Strength:
• 70% remains after 14 days
• 50% remains after 21 days
• 40% remains after 21 days
• 25% remains after 28 days
• Complete mass absorption in approximately 56-63days

Range:
USP 3-0 to 2-0

Indications:
Indicated for soft tissue approximation and ligation, where absorbable sutures are indicated, including:
• Suturing of subcutaneous tissue
• Fascia
• Joint Capsule
• Muscles
• Uterus and GI surgery
• Vascular surgery
• Ophthalmic surgery

Needle: round bodied, taperpoint 1/2 circle, 70cm suture
Needle: reverse cutting 3/8 circle, 70cm suture
Laryngo-Vac®
DESCRIPTION
Laryngo-Vac® is a monovalent modiﬁed-live virus vaccine for the immunization of chickens against infectious laryngotracheitis (ILT).

COMPOSITION
Modiﬁed-live infectious laryngotracheitis virus, Cover strain

INDICATION
Laryngo-Vac® is recommended for administration to healthy chickens to help protect against ILT.

VACCINATION PROGRAM
Vaccinate birds when they are 4 weeks old; or, if conditions dictate, birds may be vaccinated as early as 10 days of age.
Revaccinate replacement birds at 16 to 20 weeks of age.
This vaccine is recommended for the immunization of healthy birds. If an outbreak of infectious laryngotracheitis occurs on your operation, immediately institute a program of vaccination of birds farthest from the infected and work toward the infected birds.
Dosage: One dose per bird.

METHOD OF ADMINISTRATION
Eye drop (intraocular), drinking water or coarse spray: See the product insert for detailed instructions for vaccine administration.

PRESENTATION
10 x 1,000 doses

STORAGE
Store in the dark at 2°C to 7°C.
Lillidale
INDICATION:
Kills bacteria, virus and fungus through oxidative effect.
Approved by Defra for disinfection of specific virus.

COMPOSITION:
Potassium peroxomonosulfate >50%

DOSAGE AND ADMINISTRATION:
Foot bath 1: 300.
Aerial disinfection 1:150.
Water disinfection 1:250.
Drinking water disinfection 1:1000.

WITHDRAWAL PERIOD:
None.

STORAGE CONDITION:
Store below 30°C in dry place. Protect from direct sunlight.

PRECAUTION:
Keep away from children.

PACKING
5kg drum
MG-Bac®
DESCRIPTION
MG-Bac® is an inactivated vaccine for the immunization of healthy chickens and turkeys against clinical signs associated with Mycoplasma gallisepticum infection.

COMPOSITION
Inactivated M. gallisepticum.

INDICATION
MG-Bac® is recommended for vaccination of healthy chickens and healthy turkeys 1 week of age or older to protect against clinical signs associated with M. gallisepticum infection.

VACCINATION PROGRAM
Inject healthy chickens or turkeys 1 to 10 weeks of age subcutaneously (in the lower neck region) using aseptic technique. For birds 10 weeks of age or older, one may vaccinate intramuscularly or subcutaneously.
For optimum results, vaccinate twice, allowing at least 4 weeks between vaccinations. The vaccination program should be completed prior to the point of lay.
Revaccinate birds during molt before the second laying period.
Dosage: One dose (0.5 mL) per bird.

METHOD OF ADMINISTRATION
Subcutaneous injection (in the lower neck region), or intramuscularly (only in birds 10 weeks of age or older).

PRESENTATION
500 mL (1,000 doses) bottle

STORAGE
Store in the dark at 2°C to 7°C.
Do not freeze.
Mucusol
INDICATION:
Natural ingredients for Broncho-mucoexpectorant as well as loosen phlegm for effective expel from respiratory tract.
At times of respiratory disease challenge, product helps to clear airways as mucus expectorant, as well as reduce
respiratory burden against blockage.
Support disease challenge recovery such as Infectious Laryngotracheitis (ILT) and Mycoplasmosis.

COMPOSITION:
Liquid Guaiacum officinalis extract, emulsifying agent.

DOSAGE AND ADMINISTRATION:
Oral in drinking water.
For Respiratory expectorant : Mix 1L into 485L drinking water.

WITHDRAWAL PERIOD:
None.

STORAGE CONDITION:
Store below 25°C in dry place. Protect from direct sunlight.

PRECAUTION:
Keep away from children.

PACKING
1L
ND Lasota IB Mass
DESCRIPTION
ND Lasota IB Mass is a combination live virus vaccine for the immunization of chickens against Newcastle Disease and Infectious of Bronchitis.

COMPOSITION
– Live Newcastle Disease virus B1 Type, Lasota strain.
– Live infectious Bronchitis virus, Massachusetts Serotype, M41 strain.

INDICATION
– ND Lasota IB Mass is recommended for the prevention of Newcastle Disease and infectious of Bronchitis.
– For active immunisation of chickens to reduce mortality and clinical signs due to infection with Newcastle Disease and infectious of Bronchitis.

VACCINATION PROGRAM
ND Lasota IB Mass is recommended for the vaccination of healthy chickens at:
– 1 day of age or older by intranasal or intraocular administration.
– 2 weeks of age or older by drinking water administration.
– 4 weeks of age or older by spray administration.

METHOD OF ADMINISTRATION
Vaccination should be performed by eye drop/ spraying/ drinking water. (See the product insert for detailed instructions for vaccination administration).

PRESENTATION
10 x 1000 doses vials

STORAGE
Store in the dark at 2°C to 7°C.
New LS Mass 1
DESCRIPTION
New LS Mass 1 is a combination live virus vaccine for the immunization of chickens against Newcastle Disease and Infectious of Bronchitis.
COMPOSITION
Live Newcastle Disease virus B1 Type, Lasota strain.
Live Infectious Bronchitis virus, Massachusetts Serotype, H120 Strain.

INDICATION
• New LS Mass 1 is recommended for the prevention of Newcastle Disease and Infectious of Bronchitis.
• For active immunisation of chickens to reduce mortality and clinical signs due to infection with Newcastle Disease and Infectious of Bronchitis.
VACCINATION PROGRAM
New LS Mass 1 is recommended for the vaccination of healthy chickens at:
– 1 day of age or older by intranasal or intraocular administration.
– 2 weeks of age or older by drinking water administration.
– 4 weeks of age or older by spray administration.

METHOD OF ADMINISTRATION
Vaccination should be performed by eye drop/ spraying/ drinking water. (See the product insert for detailed instructions for vaccine administration).
PRESENTATION
10 x 1,000 doses vials.
STORAGE
• Store in the dark at 2°C to 7°C.

1
2
3
4
5
6
7

TOP